The START Program funds investigators entering high-priority substance use research areas, including HIV comorbidity. It supports gathering preliminary data to facilitate securing future research grants and advancing scientific careers. Clinical trials are optional under this award.
Eligible applicants include a wide range of organizations such as state and local governments, for-profit organizations, small businesses, various educational institutions, nonprofits, tribal organizations, and public housing authorities.